Home Tags FDA

FDA

AHPA Analyzes FDA Recall Data

Washington, D.C.—Dietary supplement recalls are relatively infrequent, according to recent FDA data. A statement from the American Herbal Products Association (AHPA) notes that out of...

CCA to FDA: Coconut is Not a Major Allergen

Spring, TX—The Coconut Coalition of the Americas (CCA) has launched an initiative to make it clear that coconuts are not tree nut allergens, according...

FDA Has New Portal for Submitting NDI and SFCN

Washington, DC--As part of its modernization efforts, the FDA has a new system for accepting and storing electronic submissions for new dietary ingredient notification...

Highlights from the AHPA Supplement Congress

Denver, CO--USDA and FDA officials were on hand to share important information with companies selling hemp-CBD in dietary supplements at the two-day American Herbal...

FDA Guidance for Nutrient Conversion Units on Nutrition & Supplement Facts Labels

Washington, D.C.--The Food and Drug Administration (FDA) has released a guidance for industry with step-by-step instructions for manufacturers on how to convert the previous...

Industry Reacts to Gottlieb’s Op-Ed: Agree With His Urgency, Disagree With His Methods

Washington, D.C.—Scott Gottlieb, M.D., resident fellow at the American Enterprise Institute and former commissioner of FDA, wrote an op-ed in The Washington Post calling...

Curaleaf Removes Non-Compliant CBD Claims Following FDA Warning Letter

Wakefield, MA--In response to a warning letter from the FDA stating that Curaleaf Hemp was “illegally selling unapproved products containing cannabidiol (CBD) online with...

FDA Warns CBD Company Over Unapproved New and Misbranded Drug Products

Washington, DC--The Food and Drug Administration (FDA) issued a warning letter to Curaleaf, Inc., based in Wakefield, MA, for "illegally selling unapproved products containing...
NPA

NPA Submits Comments to FDA on NDIs and CBD

Washington, DC--The Natural Products Association (NPA) has filed comments with the Food and Drug Administration (FDA) regarding its review of “Responsible Innovation in Dietary...

CRN Asks FDA: “Remove Impasses to Longstanding Issues; Promote Innovation by Protecting Intellectual Property”

College Park, MD—On May 16, FDA held a public meeting titled “Responsible Innovation in Dietary Supplements.” The meeting was intended to give interested parties...

BACK ISSUES

MULTIMEDIA